Correction: Premchandani et al. Engineered Exosomes as Smart Drug Carriers: Overcoming Biological Barriers in CNS and Cancer Therapy. Drugs Drug Candidates 2025, 4, 19

Key Points

• To evaluate the use of engineered exosomes as innovative drug carriers for therapies targeting the central nervous system (CNS) and cancer.
• Assessment of engineered exosomes' delivery efficiency.
• Analysis of biological barrier penetration in CNS.
• Evaluation of therapeutic impact in cancer models.
• Engineered exosomes effectively overcome biological barriers.
• Demonstrated targeted delivery of therapeutic agents.
• Improved drug action in CNS and cancer contexts.